Skip to main content
. 2021 Jun 10;107(1):32–38. doi: 10.1136/archdischild-2020-321309

Table 1.

Outcomes according to neonatal MRI*

Normal/Mildly abnormal MRI
(n=34)
Moderately/Severely abnormal MRI
(n=12)
Total
(n=46)
P value
Fidgety movements 0.001†
 Absent (−) 3/31 (9.7) 6/8 (75.0) 9/39 (23.1)
 Sporadic (+/−) 10/31 (32.3) 0 10/39 (25.6)
 Intermittent (+) 16/31 (51.6) 2/8 (25.0) 18/39 (46.2)
 Continual (++) 1/31 (3.2) 0 1/39 (2.6)
 Exaggerated 1/31 (3.2) 0 1/39 (2.6)
Adverse outcome‡ 5/32 (15.6) 8/11 (72.7) 13/43 (30.2) <0.001
Death 0 4/12 (33.3) 4/46 (8.7) <0.001
Bayley-III cognitive composite score 0.001
 <70 0 3/7 (42.9) 3/38 (7.9)
 70–84 4/31 (12.9) 1/7 (14.3) 5/38 (13.2)
 ≥85 27/31 (87.1) 3/7 (42.9) 30/38 (78.9)
Bayley-III motor composite score 0.002
 <70 0 3/7 (42.9) 3/38 (7.9)
 70–84 3/31 (9.7) 0 3/38 (7.9)
 ≥85 28/31 (90.3) 4/7 (57.1) 32/38 (84.2)
Cerebral palsy 1/31 (3.2) 3/7 (42.9) 4/38 (10.5) 0.002
GMFCS
 Level 1 1/31 (3.2) 1/7 (14.3) 2/38 (5.3)
 Level 5 0 2/7 (28.6) 2/38 (5.3)

Data are n/N (%). Denominators vary according to available data.

*Normal/Mildly abnormal MRI defined as normal/mild basal ganglia and thalami score and/or normal/mild/moderate white matter score. Moderately/Severely abnormal MRI defined as moderate/severe basal ganglia and thalami score and/or absent posterior limb of the internal capsule and/or severe white matter score.

†P value based on Fisher’s exact test on absent versus present FMs.

‡Adverse outcome defined as death, cerebral palsy with GMFCS level 3–5 or Bayley-III cognitive and/or motor composite score <85.

Bayley-III, Bayley Scales of Infant and Toddler Development (third edition); GMFCS, Gross Motor Function Classification System.